Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

J Allergy Clin Immunol Pract

Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.

Published: March 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2018.07.045DOI Listing

Publication Analysis

Top Keywords

mepolizumab treatment
4
treatment aspirin-exacerbated
4
aspirin-exacerbated respiratory
4
respiratory disease
4
disease associated
4
associated coronary
4
coronary spasm
4
mepolizumab
1
aspirin-exacerbated
1
respiratory
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!